Differential microRNA expression by solexa sequencing in the sera of ovarian cancer patients

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 4, 2014, Pages 1739-1743

  Ji, Ting ^a   Zheng, Zhi Guo ^b   Wang, Feng Mei ^c   Xu, Li Jian ^a   Li, Lu Feng ^a   Cheng, Qi Hui ^d   Guo, Jiang Feng ^a   Ding, Xian Feng ^a  

^a ZHEJIANG SCI TECH UNIVERSITY   (China)

^b ZHEJIANG CANCER HOSPITAL   (China)

^c Women s Hospital School of Medicine Zhejiang University   (China)

^d HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

Diagnostic biomarkers; MicroRNAs; Ovarian cancer; Serum; Solexa sequencing

Indexed keywords

CA 125 ANTIGEN; MEMBRANE PROTEIN; MICRORNA; MIRN106 MICRORNA, HUMAN; MIRN22 MICRORNA, HUMAN; MIRN451 MICRORNA, HUMAN; MIRN93 MICRORNA, HUMAN; MUC16 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; BIOSYNTHESIS; BLOOD; DNA SEQUENCE; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; OVARY TUMOR;

BASE SEQUENCE; CA-125 ANTIGEN; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MICRORNAS; MIDDLE AGED; OVARIAN NEOPLASMS; SEQUENCE ANALYSIS, DNA; TUMOR MARKERS, BIOLOGICAL;

EID: 84896928176     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.4.1739     Document Type: Article

References (36)

1. Bartel D (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97.
2. Brase J, Wuttig D, Kuner R, et al (2010), Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer, 9, 306-15.
3. Calin G, Croce C (2006). MicroRNA signatures in human cancers.Nat Rev Cancer 6, 857-66.
4. Chen X, Ba Y, Ma L, et al (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res, 18, 997-1006.
5. Chen Y, Zhang L, Hao Q (2013). Candidate microRNA biomarkers in human epithelial ovarian cancer: systematic review profiling studies and experimental validation. Cancer Cell Int, 13, 2867-86.
6. Corney D, Nikitin A (2008). MicroRNA and ovarian cancer. Histol and Histopathol, 23, 1161-9.
7. Cortez M, Calin G (2009). MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther, 9, 703-11.
8. Creighton C, Reid J, Gunaratne P (2009). Expression profiling of microRNAs by deep sequencing. Brief Bioinform, 10, 490-7.
9. Dahiya N, Sherman-Baust C, Wang T, et al (2008). MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS One 18, e2436.
10. Fu X, Tian J, Zhang L, et al (2012). Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells. FEBS Lett, 9, 1279-86.
11. Garmire L, Subramaniam S (2012). Evaluation of normalization methods in mammalian microRNA-Seq data, RNA, 18, 1279-88.
12. Iorio M, Croce C (2012). MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med, 4, 143-59.
13. Iorio M, Croce C (2012). microRNA involvement in human cancer. Carcinogenesis, 33, 1126-33.
14. Iorio M, Visone R, Di Leva G, Donati V, et al (2007). MicroRNA signatures in human ovarian cancer. Cancer Res, 67, 8699-707.
15. Kurman R, Visvanathan K, Roden R, et al (2008). Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obstet Gynecol, 198, 351-6.
16. Lee R, Ambros V (2001). An extensive class of small RNAs in Caenorhabditis elegans. Science, 294, 862-864.
17. Li J, Liang S, Lu X (2010). Potential role of ezrin and its related microRNA in ovarian cancer invasion and metastasis. Zhonghua Fu Chan Ke Za Zhi, 45, 787-92.
18. Liu X, Liu L, Xu Q (2012). MicroRNA as a novel drug target for cancer therapy. Expert Opin Biol Th, 12, 573-80.
19. Livak K, Schmittgen T (2001), Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta] CT method. Methods 25, 402-8.
20. Mitchell P, Parkin R, Kroh E, et al (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA, 105, 10513-8.
21. Moxon S, Jing R, Szittya G, et al (2008). Deep sequencing of tomato short RNAs identifies microRNAs targeting genes involved in fruit ripening. Genome Res, 18, 1602-9.
22. Nam E, Yoon H, Kim S, et al (2008), MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res, 14, 2690-5.
23. Rathjen T, Pais H, Sweetman D, et al (2009). High throughput sequencing of microRNAs in chicken somites. FEBS Lett, 583, 1422-6.
24. Resnick K, Alder H, Hagan J, et al (2009). The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol, 112, 55-9.
25. Ries L, Reichman M, Lewis D, et al (2003). Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist, 8, 541-52.
26. Rossing M,. Wicklund K, Cushing-Haugen K, et al (2010). Predictive value of symptoms for early detection of ovarian cancer. J Natl Cancer Inst, 102, 222-229.
27. Sankaranarayanan R, Ferlay J (2006). Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Cl OB, 20, 207-25.
28. Siegel R, Naishadham D, Jemal A (2013). Cancer statistics. CA Cancer J Clin, 63, 11-30.
29. Smith, R. Brooks C, et al (2013). Cancer screening in the United States. CA Cancer J Clin, 2, 87-105.
30. Van M, Helleman J, Berns E, et al (2010). MicroRNAs in ovarian cancer biology and therapy resistance. Int J Biochem Cell B, 42, 1282-90.
31. Visintin I, Feng Z, Longton G, et al (2008). Diagnostic markers for early detection of ovarian cancer. Clin Cancer Res, 14, 1065-72.
32. Visone R, Croce C (2008). MicroRNA. Wiley Encyclopedia of Chemical Biology, 5, 1-9.
33. Wan, SM, Lv F, et al (2012). Identification of genes and microRNAs involved in ovarian carcinogenesis. Asian Pac J Cancer P, 13, 3997-4000.
34. Wu Q, Lu Z, Li H, et al (2011). Next-generation sequencing of microRNAs for breast cancer detection. J Biomed Biotechnology. 2011, 597145-52.
35. Wyman S, Parkin R, Mitchell P, et al (2009). Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS One, 4, e5311.
36. Xu YZ, Xi QH, Ge WL, Zhang XQ (2013). Identification of serum microrna-21 as a biomarker for early detection and prognosis in human epithelial ovarian cancer. Asian Pac J Cancer Prev, 14, 1057-60.